Selected research
Industry Research
Activin and Inhibin Industry Research Report 2026
Market perspective
The global Activin and Inhibin market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Activin and Inhibin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Activin and Inhibin is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Activin and Inhibin is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Activin and Inhibin include Thermo Fisher Scientific, StemRD, STEMCELL, Sino Biological, ReproCELL, Proteintech Group, Prospec, PeproTech and Merck Millipore, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Activin and Inhibin market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Activin and Inhibin Market by Company
Thermo Fisher Scientific
StemRD
STEMCELL
Sino Biological
ReproCELL
Proteintech Group
Prospec
PeproTech
Merck Millipore
IBL
Enzo Life Sciences
Bio-Techne
Ajinomoto
Activin and Inhibin Segment by Type
Activin
Inhibin
Activin and Inhibin Segment by Application
Commercial Research
Academic Research
Activin and Inhibin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Activin and Inhibin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Activin and Inhibin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Activin and Inhibin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Activin and Inhibin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Activin and Inhibin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Activin and Inhibin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Activin
- Inhibin
Applications
- Commercial Research
- Academic Research
Companies covered
- Thermo Fisher Scientific
- StemRD
- STEMCELL
- Sino Biological
- ReproCELL
- Proteintech Group
- Prospec
- PeproTech
- Merck Millipore
- IBL
- Enzo Life Sciences
- Bio-Techne
- Ajinomoto
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Activin and Inhibin Market Size (2021-2032)
- 2.2.2 Global Activin and Inhibin Sales (2021-2032)
- 2.2.3 Global Activin and Inhibin Market Average Price (2021-2032)
- 2.3 Activin and Inhibin by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Activin
- 2.3.3 Inhibin
- 2.4 Activin and Inhibin by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Commercial Research
- 2.4.3 Academic Research
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Activin and Inhibin Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Activin and Inhibin Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Activin and Inhibin Revenue of Manufacturers (2021-2026)
- 3.4 Global Activin and Inhibin Average Price by Manufacturers (2021-2026)
- 3.5 Global Activin and Inhibin Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Activin and Inhibin, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Activin and Inhibin, Product Type & Application
- 3.8 Global Manufacturers of Activin and Inhibin, Established Date
- 3.9 Global Activin and Inhibin Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Thermo Fisher Scientific
- 4.1.1 Thermo Fisher Scientific Company Information
- 4.1.2 Thermo Fisher Scientific Business Overview
- 4.1.3 Thermo Fisher Scientific Activin and Inhibin Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Thermo Fisher Scientific Activin and Inhibin Product Portfolio
- 4.1.5 Thermo Fisher Scientific Recent Developments
- 4.2 StemRD
- 4.2.1 StemRD Company Information
- 4.2.2 StemRD Business Overview
- 4.2.3 StemRD Activin and Inhibin Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 StemRD Activin and Inhibin Product Portfolio
- 4.2.5 StemRD Recent Developments
- 4.3 STEMCELL
- 4.3.1 STEMCELL Company Information
- 4.3.2 STEMCELL Business Overview
- 4.3.3 STEMCELL Activin and Inhibin Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 STEMCELL Activin and Inhibin Product Portfolio
- 4.3.5 STEMCELL Recent Developments
- 4.4 Sino Biological
- 4.4.1 Sino Biological Company Information
- 4.4.2 Sino Biological Business Overview
- 4.4.3 Sino Biological Activin and Inhibin Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Sino Biological Activin and Inhibin Product Portfolio
- 4.4.5 Sino Biological Recent Developments
- 4.5 ReproCELL
- 4.5.1 ReproCELL Company Information
- 4.5.2 ReproCELL Business Overview
- 4.5.3 ReproCELL Activin and Inhibin Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 ReproCELL Activin and Inhibin Product Portfolio
- 4.5.5 ReproCELL Recent Developments
- 4.6 Proteintech Group
- 4.6.1 Proteintech Group Company Information
- 4.6.2 Proteintech Group Business Overview
- 4.6.3 Proteintech Group Activin and Inhibin Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Proteintech Group Activin and Inhibin Product Portfolio
- 4.6.5 Proteintech Group Recent Developments
- 4.7 Prospec
- 4.7.1 Prospec Company Information
- 4.7.2 Prospec Business Overview
- 4.7.3 Prospec Activin and Inhibin Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Prospec Activin and Inhibin Product Portfolio
- 4.7.5 Prospec Recent Developments
- 4.8 PeproTech
- 4.8.1 PeproTech Company Information
- 4.8.2 PeproTech Business Overview
- 4.8.3 PeproTech Activin and Inhibin Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 PeproTech Activin and Inhibin Product Portfolio
- 4.8.5 PeproTech Recent Developments
- 4.9 Merck Millipore
- 4.9.1 Merck Millipore Company Information
- 4.9.2 Merck Millipore Business Overview
- 4.9.3 Merck Millipore Activin and Inhibin Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Merck Millipore Activin and Inhibin Product Portfolio
- 4.9.5 Merck Millipore Recent Developments
- 4.10 IBL
- 4.10.1 IBL Company Information
- 4.10.2 IBL Business Overview
- 4.10.3 IBL Activin and Inhibin Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 IBL Activin and Inhibin Product Portfolio
- 4.10.5 IBL Recent Developments
- 4.11 Enzo Life Sciences
- 4.11.1 Enzo Life Sciences Company Information
- 4.11.2 Enzo Life Sciences Business Overview
- 4.11.3 Enzo Life Sciences Activin and Inhibin Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Enzo Life Sciences Activin and Inhibin Product Portfolio
- 4.11.5 Enzo Life Sciences Recent Developments
- 4.12 Bio-Techne
- 4.12.1 Bio-Techne Company Information
- 4.12.2 Bio-Techne Business Overview
- 4.12.3 Bio-Techne Activin and Inhibin Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Bio-Techne Activin and Inhibin Product Portfolio
- 4.12.5 Bio-Techne Recent Developments
- 4.13 Ajinomoto
- 4.13.1 Ajinomoto Company Information
- 4.13.2 Ajinomoto Business Overview
- 4.13.3 Ajinomoto Activin and Inhibin Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Ajinomoto Activin and Inhibin Product Portfolio
- 4.13.5 Ajinomoto Recent Developments
5 Global Activin and Inhibin Market Scenario by Region
- 5.1 Global Activin and Inhibin Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Activin and Inhibin Sales by Region: 2021-2032
- 5.2.1 Global Activin and Inhibin Sales by Region: 2021-2026
- 5.2.2 Global Activin and Inhibin Sales by Region: 2027-2032
- 5.3 Global Activin and Inhibin Revenue by Region: 2021-2032
- 5.3.1 Global Activin and Inhibin Revenue by Region: 2021-2026
- 5.3.2 Global Activin and Inhibin Revenue by Region: 2027-2032
- 5.4 North America Activin and Inhibin Market Facts & Figures by Country
- 5.4.1 North America Activin and Inhibin Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Activin and Inhibin Sales by Country (2021-2032)
- 5.4.3 North America Activin and Inhibin Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Activin and Inhibin Market Facts & Figures by Country
- 5.5.1 Europe Activin and Inhibin Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Activin and Inhibin Sales by Country (2021-2032)
- 5.5.3 Europe Activin and Inhibin Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Activin and Inhibin Market Facts & Figures by Country
- 5.6.1 Asia Pacific Activin and Inhibin Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Activin and Inhibin Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Activin and Inhibin Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Activin and Inhibin Market Facts & Figures by Country
- 5.7.1 South America Activin and Inhibin Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Activin and Inhibin Sales by Country (2021-2032)
- 5.7.3 South America Activin and Inhibin Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Activin and Inhibin Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Activin and Inhibin Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Activin and Inhibin Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Activin and Inhibin Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Activin and Inhibin Sales by Type (2021-2032)
- 6.1.1 Global Activin and Inhibin Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Activin and Inhibin Sales Market Share by Type (2021-2032)
- 6.2 Global Activin and Inhibin Revenue by Type (2021-2032)
- 6.2.1 Global Activin and Inhibin Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Activin and Inhibin Revenue Market Share by Type (2021-2032)
- 6.3 Global Activin and Inhibin Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Activin and Inhibin Sales by Application (2021-2032)
- 7.1.1 Global Activin and Inhibin Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Activin and Inhibin Sales Market Share by Application (2021-2032)
- 7.2 Global Activin and Inhibin Revenue by Application (2021-2032)
- 7.2.1 Global Activin and Inhibin Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Activin and Inhibin Revenue Market Share by Application (2021-2032)
- 7.3 Global Activin and Inhibin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Activin and Inhibin Value Chain Analysis
- 8.1.1 Activin and Inhibin Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Activin and Inhibin Production Mode & Process
- 8.2 Activin and Inhibin Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Activin and Inhibin Distributors
- 8.2.3 Activin and Inhibin Customers
9 Global Activin and Inhibin Analyzing Market Dynamics
- 9.1 Activin and Inhibin Industry Trends
- 9.2 Activin and Inhibin Industry Drivers
- 9.3 Activin and Inhibin Industry Opportunities and Challenges
- 9.4 Activin and Inhibin Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst